Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Carotid Endarterectomy
NCT03115034Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of melatonin in reperfusion injury (IRI) (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Superoxide Dismutase at 3 months, Malonaldehyde at 3 months and 5 more. Started Jun 2016; status: completed.
02
Drugs
melatonin
03
Conditions
reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT03115034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03115034.